NVUAtlas: A Comprehensive Single-Nucleus RNA-Seq Resource for the Human Neurovascular Unit in Alzheimer's Disease
Biorxiv : the Preprint Server for Biology
|December 31, 2025
Summary
Alzheimer's disease (AD) involves neurovascular unit (NVU) dysfunction. Our Human NVU Atlas reveals sex-specific vascular changes and disrupted cell communication, highlighting vascular cells' critical role in AD progression.
Area of Science:
- Neuroscience
- Genomics
- Cell Biology
Background:
- Neurovascular unit (NVU) dysfunction is an early factor in Alzheimer's disease (AD) pathogenesis.
- Standard single-nucleus RNA sequencing (snRNA-seq) lacks resolution for NVU vascular and mural cells.
- Existing transcriptomic atlases do not capture intercellular signaling in NVU vascular components like endothelial cells and pericytes.
Purpose of the Study:
- To construct a high-resolution transcriptomic atlas of the human NVU.
- To investigate NVU dysfunction at the molecular level, focusing on vascular cells.
- To identify sex-specific differences in NVU molecular mechanisms in AD.
Main Methods:
- Integrated 11 vascular-enriched snRNA-seq datasets from the human prefrontal cortex.
- Utilized deep generative models (SCVI) for batch-aware integration of over 4.2 million nuclei.
- Employed advanced classifiers for cell type re-annotation and performed differential expression and ligand-receptor analyses.
Main Results:
- Assembled the largest public NVU cohort, including endothelial cells and pericytes.
- Observed transcriptional hyperactivity (gene upregulation) in vascular cells in AD, contrasting neuronal downregulation.
- Identified sex-specific vulnerabilities: females showed inflammatory signatures and reduced collagen gene expression in pericytes.
Conclusions:
- The Human NVU Atlas offers a detailed transcriptomic framework for studying NVU cellular heterogeneity.
- Revealed sex-specific vascular mechanisms and disrupted intercellular communication in AD.
- Underscores the importance of vascular cells and extracellular matrix integrity in AD pathogenesis.


